SEITO Biologics is a preclinical biotechnology startup.
SEITO Biologics has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
SEITO Biologics's investors include Lichtsteiner Foundation.
SEITO Biologics is headquartered in Zurich, Switzerland.
SEITO Biologics is a preclinical biotechnology startup.
SEITO Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SEITO Biologics — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/seito-biologics. Accessed August 1, 2026.
VCBacked. (2025). SEITO Biologics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/seito-biologics
{{cite web |title=SEITO Biologics — Funding & Investors |url=https://www.vcbacked.co/company/seito-biologics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated